Impact and Insight News blends space, science, technology, and combat sports into one forward-looking newsroom. We report where innovation, discovery, and human intensity intersect. This is where impact creates insight.
Follow us on social media:
Featured Stories Coming Soon
Get link
Facebook
X
Pinterest
Email
Other Apps
-
This section highlights selected stories across space, science, and combat sports.
Featured posts will be added here as we publish more content.
Remy Scott MMA News & Recap Writer You can tell how far MMA has come by who still looks fresh after round one. At UFC 323, that group probably includes the champions. Merab Dvalishvili and Alexandre Pantoja fight like rest days are optional. They are the new prototype: tireless, tactical, and terrifying in their efficiency. If the early UFC was chaos, this era is control. The first wave of fighters went in swinging. Tank Abbott threw like gravity didn’t matter. Chuck Liddell stared through people. Vitor Belfort was all speed and adrenaline. It was wild and unforgettable, but the game changed. Today’s champions fight like endurance athletes trapped in a brawl. Their secret weapon isn’t brute strength. It’s the ability to keep performing when everyone else is gasping for air. The New Blueprint: Pressure Without Panic Merab Dvalishvili doesn’t surprise opponents; he suffocates them. From the opening bell, he builds pressure that never lets up. Every ...
Nathan Arlow Tech & Future Science Writer Magnetically guided microrobots developed at ETH Zurich. Image credit: ETH Zurich. They swim through blood vessels, crawl along tissue, and carry medicines smaller than a speck of dust. 2025 has quietly become the year of the micro-robot. Once confined to speculative sketches and sci-fi storyboards, these machines now appear in peer-reviewed journals, press releases, and early clinical trials. At ETH Zurich, researchers demonstrated microrobots small enough to slip through capillary models and steer magnetically toward simulated clots. In July, a collaboration between the University of Michigan and Oxford University revealed micro-swimmers that can carry drug payloads through complex fluid environments while maintaining directional control. In September, the U.S. Food and Drug Administration granted Microbot Medical’s Liberty system a 510(k) clearance, marking the first time a company has won formal recogniti...
Elliot Fray Science Reporter Several CRISPR-based treatments for blood disorders and rare genetic diseases have entered broader multi-center evaluations this month, marking a cautious but meaningful expansion in gene-editing research. These trials build on earlier safety studies that demonstrated stable editing in targeted cells, though long-term impacts are still being closely monitored. Stylized CRISPR-Cas9 illustration showing DNA strands being cut. Image credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH (public domain). What the New Trials Are Designed to Measure The expanded studies focus on conditions such as sickle cell disease, beta-thalassemia, and select immune disorders where a single genetic change plays a major role in symptoms. According to publicly available trial protocols, researchers are emphasizing three areas: Editing efficiency: How consistently the CRISPR system edits the intended gene across large p...
Comments
Post a Comment